about
New insights into HIV-1-primary skin disordersLow expression of the IL-23/Th17 pathway in atopic dermatitis compared to psoriasis.7,8,4'-Trihydroxyisoflavone attenuates DNCB-induced atopic dermatitis-like symptoms in NC/Nga mice.Oclacitinib (APOQUEL(®)) is a novel Janus kinase inhibitor with activity against cytokines involved in allergy.Chromosome 11q13.5 variant associated with childhood eczema: an effect supplementary to filaggrin mutationsAtopic dermatitis results in intrinsic barrier and immune abnormalities: implications for contact dermatitis.Efficacy and safety of oclacitinib for the control of pruritus and associated skin lesions in dogs with canine allergic dermatitis.A blinded, randomized, placebo-controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel®) in client-owned dogs with atopic dermatitis.Atopic dermatitis patients carrying G allele in -1082 G/A IL-10 polymorphism are predisposed to higher serum concentration of IL-10.Identification of novel immune and barrier genes in atopic dermatitis by means of laser capture microdissection.Aberrant Wound Healing in an Epidermal Interleukin-4 Transgenic Mouse Model of Atopic DermatitisChlorella vulgaris Attenuates Dermatophagoides Farinae-Induced Atopic Dermatitis-Like Symptoms in NC/Nga Mice.Clinical Features of Adult/Adolescent Atopic Dermatitis and Chinese Criteria for Atopic Dermatitis.Association of staphylococcal superantigen-specific immunoglobulin e with mild and moderate atopic dermatitis.Oral administration of SSC201, a medicinal herbal formula, suppresses atopic dermatitis-like skin lesionsMechanisms of leukocyte trafficking in allergic diseases: insights into new therapies targeting chemokines and chemokine receptors.Eczema in early life: genetics, the skin barrier, and lessons learned from birth cohort studies.Galectin-3 and the skinHSP: Bystander Antigen in Atopic Diseases?Molecular biology of atopic dermatitis.Junctions and inflammation in the skin.Epidermal tight junctions in health and disease.Autoallergy in atopic dermatitis.Evolving Concepts in Atopic Dermatitis.Increased ZAP70 Is Involved in Dry Skin Pruritus in Aged Mice.Evaluation of Immune Indices and Serum Vitamin D Content in Children with Atopic Dermatitis.Conditional knock out of N-WASP in keratinocytes causes skin barrier defects and atopic dermatitis-like inflammation.Tacrolimus ointment in the management of atopic dermatitis.Transgenic expression of interleukin-13 in the skin induces a pruritic dermatitis and skin remodeling.Expression levels of transcription factor PU.1 and interleukin-9 in atopic dermatitis and their relation to disease severity and eruption types.T helper (Th)1, Th17 and Th2 imbalance in mesenchymal stem cells of adult patients with atopic dermatitis: at the origin of the problem.Serum anti-Staphylococcus pseudintermedius IgE and IgG antibodies in dogs with atopic dermatitis and nonatopic dogs.The role of T-cell reactivity towards the autoantigen α-NAC in atopic dermatitis.The pharmacokinetics of oclacitinib maleate, a Janus kinase inhibitor, in the dog.Investigation of Immune-Regulatory Effects of Mageumsan Hot Spring via Protein Microarray In Vitro.
P2860
Q21198772-B719A097-4FA1-4750-ACDF-02E6A482B9E7Q30525640-B27E7610-AD59-4ED6-B37B-A5E5EED19A4CQ34109984-6C2B56F9-A265-46C7-AFDE-CB9FFE4BC0EDQ34402215-C4091A8E-EA97-4BF4-B724-2B08A8B1F77DQ34571051-46E06650-35CF-4572-84E7-E0EFD3B58908Q34797596-2AF6412F-F970-4696-A4B9-08E068796DFBQ34805412-033405A6-D02F-4944-87FB-F582478979D7Q34866838-571A7A98-4C2C-4B7E-BD0C-540F88EB27E6Q34974365-29DE58BA-1F86-49D3-8EAF-9FE5754010DEQ35539472-1216DFD5-B9F8-4347-B39F-B8354A6299EAQ35890345-6C8B2392-0189-4FCE-BD2D-64EBFAFEBDE3Q36184047-3D64C660-F394-4C01-9F74-CAC17EFFDE98Q36760937-4082EF1D-3F84-49DD-B266-A400D8DE789FQ37029779-3CE985D7-49C3-4DE3-A125-EFA2D62E56B7Q37712713-F6B2EB53-0302-49DB-9012-3EA94BAF359CQ37755318-8190388E-C700-4A01-BC95-5A5178CEC6E5Q37782462-19B7D593-E769-49DC-9DC6-5F83F04D1208Q37926145-824CDCA9-F4C9-464B-A9BD-780F7EA9CD43Q38016152-B37288F0-104A-434A-A41C-3F52936CA33AQ38203185-128349D6-2B16-4699-8F02-A062A3FBD710Q38208612-D01BCCD3-7E0B-4936-B020-DC72B1B0021CQ38403654-BACBD77A-86D1-42AF-97B8-6B824A1898C7Q38539747-7C64516E-1D1C-40E9-B94D-8763E91F14D4Q39337195-76D94A38-52C1-4E22-B6E8-02FC9E344BB5Q39754258-67332B65-C3FA-4BFB-B6CB-644FEA86262BQ40198643-5EAFCC73-866D-4536-A1C4-18345DE4BB54Q41260707-ACB9DD23-C81A-413B-A864-58EDD3599D4CQ42081579-0BCB4888-281F-4035-B6AF-97841DFD6779Q43183078-1E2F5CFA-5634-46B4-BEE1-C41CC33BA601Q50877612-3BDDA713-37C6-4974-AEE2-95EAA9E1E102Q51496285-626D36FC-4096-44DE-8706-4E34A04AA2D2Q52842057-5F7F0F93-A09C-4DC6-828D-13200410BEE1Q53293632-EF501AF6-02D6-4E3E-8A2B-DB299F5D3797Q54453353-A26D4113-F295-4EDB-8F66-727FE105B800Q55414723-390DCE80-19E6-416D-ABF7-842F60BF847D
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Immune dysregulation in atopic dermatitis.
@ast
Immune dysregulation in atopic dermatitis.
@en
type
label
Immune dysregulation in atopic dermatitis.
@ast
Immune dysregulation in atopic dermatitis.
@en
prefLabel
Immune dysregulation in atopic dermatitis.
@ast
Immune dysregulation in atopic dermatitis.
@en
P2860
P1476
Immune dysregulation in atopic dermatitis.
@en
P2093
Donald Y M Leung
Peck Y Ong
P2860
P2888
P304
P356
10.1007/S11882-996-0008-5
P577
2006-09-01T00:00:00Z